Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (481-490 of 625) with videos related to

Pageof 63
Sort By:
Frontiers in Oncology|April 4, 2022
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail PatientsMaria Teresa Lupo-Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Contemporary Clinical Trials|October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocolMaria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
The Journal of Rheumatology|January 17, 2012
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgiaAntonio Marchesoni, Fabiola Atzeni, Antonio Spadaro, et al.
Ocular Immunology and Inflammation|August 11, 2021
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined ChemotherapyFabrizio Gozzi, Raffaella Aldigeri, Valentina Mastrofilippo, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 12, 2023
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug AntibodiesMatteo Sensi, Rafael Furlan de Oliveira, Marcello Berto, et al.
Frontiers in Pharmacology|January 24, 2019
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Antonella Insalaco, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life studyRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 3, 2024
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infectionIlaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
RMD Open|February 11, 2026
Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experienceArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Scientific Reports|September 2, 2016
Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsulaMarco Sazzini, Guido Alberto Gnecchi Ruscone, Cristina Giuliani, et al.
Pageof 63

Showing results (481-490 of 625) with videos related to

Sort By:
Pageof 63
Frontiers in Oncology|April 4, 2022
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail PatientsMaria Teresa Lupo-Stanghellini, Serena Di Cosimo, Massimo Costantini, et al.
Contemporary Clinical Trials|October 8, 2020
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocolMaria Carmela Piccirillo, Paolo Ascierto, Luigi Atripaldi, et al.
The Journal of Rheumatology|January 17, 2012
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgiaAntonio Marchesoni, Fabiola Atzeni, Antonio Spadaro, et al.
Ocular Immunology and Inflammation|August 11, 2021
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined ChemotherapyFabrizio Gozzi, Raffaella Aldigeri, Valentina Mastrofilippo, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 12, 2023
Reduced Graphene Oxide Electrolyte-Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti-Drug AntibodiesMatteo Sensi, Rafael Furlan de Oliveira, Marcello Berto, et al.
Frontiers in Pharmacology|January 24, 2019
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Antonella Insalaco, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|May 5, 2022
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life studyRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 3, 2024
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infectionIlaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
RMD Open|February 11, 2026
Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experienceArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Scientific Reports|September 2, 2016
Complex interplay between neutral and adaptive evolution shaped differential genomic background and disease susceptibility along the Italian peninsulaMarco Sazzini, Guido Alberto Gnecchi Ruscone, Cristina Giuliani, et al.
Pageof 63